2024-03-26時点での日本化薬の最新海外論文 30本(英語)です。
●Association between skin toxicity and efficacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM.
ESMO open,2024 Mar 22
https://pubmed.ncbi.nlm.nih.gov/38520847
●[Enhancement of Antitumor Effect by the Combined Use of Anti-EGFR Antibody(Necitumumab)and PD-1 Inhibitor].
Gan to kagaku ryoho. Cancer & chemotherapy,
https://pubmed.ncbi.nlm.nih.gov/38247069
●Discovery of flometoquin, a novel quinoline insecticide.
Journal of pesticide science,
https://pubmed.ncbi.nlm.nih.gov/38090218
●Real-World Safety and Efficacy of Biosimilar CT-P13 in Patients with Immune-Mediated Inflammatory Diseases: Integrated Analysis of Three Japanese Prospective Observational Studies.
Drug safety,2023 Sep 12
https://pubmed.ncbi.nlm.nih.gov/37700154
●Multicenter Randomized Open-Label Phase II Clinical Study Comparing Outcomes of NK105 and Paclitaxel in Advanced or Recurrent Breast Cancer.
International journal of nanomedicine,2022 Sep 27
https://pubmed.ncbi.nlm.nih.gov/36217496
●Thermoelectrochemical Seebeck coefficient and viscosity of Co-complex electrolytes rationalized by the Einstein relation, Jones-Dole B coefficient, and quantum-chemical calculations.
Physical chemistry chemical physics : PCCP,2022 Sep 14
https://pubmed.ncbi.nlm.nih.gov/36047310
●Safety, efficacy, and drug survival of the infliximab biosimilar CT-P13 in post-marketing surveillance of Japanese patients with psoriasis.
The Journal of dermatology,2022 Jul 7
https://pubmed.ncbi.nlm.nih.gov/35799412
●Growth of Single-Walled Carbon Nanotubes from Solid Carbon Nanoparticle Seeds via Cap Formation Engineering with a Two-Step Growth Process and Water Vapor Supply.
ACS omega,2022 Jan 20
https://pubmed.ncbi.nlm.nih.gov/35128272
●Real-world safety and efficacy of CT-P13, an infliximab biosimilar, in Japanese rheumatoid arthritis patients naïve to or switched from biologics.
Modern rheumatology,
https://pubmed.ncbi.nlm.nih.gov/34918129
●Qualitative analysis of actual Standard for Exchange of Nonclinical Data (SEND) datasets for Data Domains: Proposition from Japan Pharmaceutical Manufacturers Association SEND Taskforce Team on standardization of nonclinical data.
Regulatory toxicology and pharmacology : RTP,2021 Mar 20
https://pubmed.ncbi.nlm.nih.gov/33753112
●Binding affinities of paclitaxel and docetaxel for generic and nanoparticle albumin-bound paclitaxel-derived albumin from human serum.
Biomedical reports,2021 Feb 11
https://pubmed.ncbi.nlm.nih.gov/33732454
●Post-marketing analysis for biosimilar CT-P13 in inflammatory bowel disease compared with external data of originator infliximab in Japan.
Journal of gastroenterology and hepatology,2021 Jan 31
https://pubmed.ncbi.nlm.nih.gov/33450057
●The preparation and validation of chitosan tablets that rapidly disperse and disintegrate as an oral adsorbent in the treatment of lifestyle-related diseases.
Carbohydrate polymers,2020 Oct 21
https://pubmed.ncbi.nlm.nih.gov/33279001
●Triazolopyrimidine derivative NK026680 and donor-specific transfusion induces CD4(+)CD25(+)Foxp3(+) T cells and ameliorates allograft rejection in an antigen-specific manner.
Transplant immunology,2020 Oct 3
https://pubmed.ncbi.nlm.nih.gov/33022372
●Involvement of non‑triple helical type VI collagen α1 chain, NTH α1(VI), in the proliferation of cancer cells.
Oncology reports,2020 Aug 13
https://pubmed.ncbi.nlm.nih.gov/33000277
●Robust Nanoparticle Morphology and Size Analysis by Atomic Force Microscopy for Standardization.
Chemical & pharmaceutical bulletin,
https://pubmed.ncbi.nlm.nih.gov/32741922
●Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.
The Journal of biological chemistry,2020 Jul 6
https://pubmed.ncbi.nlm.nih.gov/32631954
●Restricted mean survival time as a summary measure of time-to-event outcome.
Pharmaceutical statistics,2020 Feb 18
https://pubmed.ncbi.nlm.nih.gov/32072769
●Development of a Rapid in vivo Assay to Evaluate the Efficacy of IRE1-specific Inhibitors of the Unfolded Protein Response Using Medaka Fish.
Cell structure and function,2019 Dec 26
https://pubmed.ncbi.nlm.nih.gov/31875595
●Infliximab biosimilar CT-P13 is interchangeable with its originator for patients with inflammatory bowel disease in real world practice.
Intestinal research,2019 Aug 23
https://pubmed.ncbi.nlm.nih.gov/31422647
●Fibroblast growth factor signals regulate transforming growth factor-β-induced endothelial-to-myofibroblast transition of tumor endothelial cells via Elk1.
Molecular oncology,2019 Jun 19
https://pubmed.ncbi.nlm.nih.gov/31094056
●Crystal structure of benzyl 2-naphthyl ether, a sensitiser for thermal paper.
Acta crystallographica. Section E, Crystallographic communications,2019 Jan 18
https://pubmed.ncbi.nlm.nih.gov/30800459
●Design and Evaluation of An Extended-Release Olmesartan Tablet Using Chitosan/Cyclodextrin Composites.
Pharmaceutics,2019 Feb 15
https://pubmed.ncbi.nlm.nih.gov/30781383
●A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients.
British journal of cancer,2019 Feb 12
https://pubmed.ncbi.nlm.nih.gov/30745582
●Identification of a common epitope in the sequences of COL4A1 and COL6A1 recognized by monoclonal antibody #141.
Journal of biochemistry,
https://pubmed.ncbi.nlm.nih.gov/30321347
●Evaluating exposure using confidence intervals: implication in tiered quantitation of metabolites for safety risks.
Bioanalysis,
https://pubmed.ncbi.nlm.nih.gov/30295549
●Cell-based chemical fingerprinting identifies telomeres and lamin A as modifiers of DNA damage response in cancer cells.
Scientific reports,2018 Oct 4
https://pubmed.ncbi.nlm.nih.gov/30287851
●A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients.
Cancer chemotherapy and pharmacology,2018 Oct 4
https://pubmed.ncbi.nlm.nih.gov/30284603
●Long-lasting immunosuppressive effects of tacrolimus-loaded micelle NK61060 in preclinical arthritis and colitis models.
Therapeutic delivery,
https://pubmed.ncbi.nlm.nih.gov/30277135
●Collaborative Study for Analysis of Subvisible Particles Using Flow Imaging and Light Obscuration: Experiences in Japanese Biopharmaceutical Consortium.
Journal of pharmaceutical sciences,2018 Aug 16
https://pubmed.ncbi.nlm.nih.gov/30121316
https://pubmed.ncbi.nlm.nih.gov/より作成
